Li J, Chory J (1997) A putative leucine-rich repeat receptor kinase involved in brassinosteroid signal transduction
Conflict of interest SK was employed by Kar Clinic and Hospital Pvt., Ltd
All Products can be purchased in any available quantity
Hay D.L., Chen S., Lutz T.A., et al
Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)
Vegetarian status unknown Unrecognized ingredients: n-acetyl-l-carnitine-hydrochloride, non-medicinal-ingredients, lubricant Some ingredients could not be recognized